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Introduction. Spasticity is a disabling symptom resulting from reorganization of spinal reflexes, which are no longer inhibited by
supraspinal control. Several studies have demonstrated interesting clinical and electrophysiological effects of repetitive transcranial
magnetic stimulation in spastic patients. We conducted a prospective, randomized, double-blind, crossover study on five spastic
hemiparetic patients to determine whether this type of stimulation of the premotor cortex can provide a clinical benefit in
these patients. Material and Methods. Two stimulation frequencies (1Hz and 10Hz) were tested versus placebo. Patients were
assessed clinically (14 parameters) and by quantitative analysis of walking (11 parameters) and bymeasurement of neuromechanical
parameters (direct motor responses (M), H and T reflexes, and musculoarticular stiffness of the ankle). Results. No change was
observed after placebo and 10Hz protocols. Clinical parameters were not significantly modified after 1Hz stimulation, apart from
a tendency towards improved recruitment of antagonist muscles on the Fu¨gl-Meyer scale. Only cadence and recurvatum were
significantly modified on quantitative analysis of walking. Neuromechanical parameters were modified with significant decreases
in𝐻max/𝑀max and 𝑇/𝑀max ratios and stiffness indices 9 days or 31 days after initiation of TMS. Conclusion.This preliminary study
supports the efficacy of low-frequency TMS to reduce reflex excitability and stiffness of ankle plantar flexors, while clinical signs of
spasticity were not significantlymodified.These preliminary findingsmust be confirmed on a larger population of patients. Clinical
trial registration no. 2011-A00298-3.
1. Introduction
1
2
Any central nervous system lesion induces major reorga-
nization of partially denervated underlying structures. The
definition of spasticity, resulting from reorganization of
spinal segmental reflexes, which no longer subjected3
to supraspinal control, was established by Lance [1] and
was recently modified by the EU-SPASM consortium: [2]
“Spasticity-disordered sensorimotor control, resulting from an
upper motor neuron lesion, presenting as intermittent or
sustained involuntary activation of muscles.” The prevalence
of spasticity varies according to the type of brain lesion:
more than 90% in cerebral palsy [3], almost 50% after head
injury [4], 37 to 78% in multiple sclerosis (MS) [5, 6], and 19
to 35% after stroke [7]. Spasticity predominantly affects the
extensor, postural, and antigravity muscles of the lower limbs
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[8, 9]. Spasticity of the foot results in equinus deformity due
to overactivity of triceps surae and varus deformity due to
overactivity of inversion muscles and weakness of eversion
muscles. All these deformities are responsible for unstable
gait support, with or without pain, poor clearance of the
foot during the swing phase, difficulty wearing shoes, and
limitation of walking distance.4
The cerebral cortex exerts a powerful inhibitory effect
on muscle tone, mediated via the reticular formation, as
the ventromedial medullary reticular formation decreases
muscle tone with a facilitating effect of the premotor cortex
[8]. On the basis of these findings, repetitive transcranial
magnetic stimulation (rTMS) must therefore be targeted to
the premotor cortex in order to reinforce suprasegmental
inhibition and consequently decrease spasticity.5
Three published trials have demonstrated interesting
effects of rTMS on spastic symptoms using various frequen-
cies and various targets, on H reflexes in healthy subjects
[10], spasticity in MS patients [11], and decreased spasticity
in combination with neurological recovery [12].
We therefore conducted a prospective, randomized,
double-blind study of the effects of rTMS on clinical, func-
tional, and neuromechanical parameters in patients with
disabling spastic hemiplegia.6
2. Material and Methods
2.1. Population. Five patients (5 men with a mean age of 56
years [46–75 years]) with spastic hemiparesis were consecu-
tively included in this study by amultidisciplinary “spasticity”
clinic. These 5 patients presented left-sided hemiparesis.
Spastic hemiparesis was secondary to stroke in 4 patients
(hemorrhagic stroke in 3 cases and ischemic stroke in 1 case)
and intracranial tumour surgery (convexity meningioma,
right central sulcus) in 1 case.7
2.2. Stimulation Protocol and Parameters. According to a
number of animal studies, the premotor cortex is a powerful
regulator of contralateral muscle tone [13, 14]. The premo-
tor cortex, integrating extrapyramidal pathways, is situated,
according to the cytoarchitectural studies of Brodmann (Area
6) followed by Vogt (Area 6𝛼𝛽), at the intersection of the
superior frontal sulcus and the precentral gyrus [15]. This
area appears to facilitate activation of dorsal reticulospinal
pathways located in the ventromedial medullary reticular
formation [16] and projecting onto the spinal cord via a dorsal
reticulospinal tract, which inhibit muscle tone. The objective
of this studywas therefore tomodulate this cortical regulation
of spinal reflex activity, the suppression of which, following
a supraspinal lesion, constitutes the pathophysiological basis
for spasticity.
Each of the stimulation protocols was targeted to the
premotor cortex on the side of the lesion (i.e, the hemisphere
contralateral to the side of spastic hemiparesis). According
to the literature, the premotor cortex would appear to be the
most promising target in this indication [11, 12].This zonewas
identified by neuronavigation based on acquisition of a 3D T1
MRI sequence for each patient. Anatomical correspondence
Table 1: Course of clinical parameters (mean ± standard deviation)
during the 1Hz and 10Hz († brackets) stimulation protocols: before
(D0) and after (D9: early assessment; D31: late assessment).
Parameter D0 D9 D31
Modified Ashworth
Knee flexed/rapid speed 2.0 ± 0.9
2.0 ± 0.9
[2.0 ± 0.9]†
2.0 ± 1.1
[2.0 ± 1.0]†
Modified Ashworth
Knee extended/rapid speed 2.2 ± 0.8
2.2 ± 0.8
[2.2 ± 0.8]†
2.2 ± 0.8
[2.2 ± 0.8]†
Recruitment of antagonists 1.0 ± 0.8 1.3 ± 1.3
[1.2 ± 1.3]†
1.8 ± 1.7∗
[1.3 ± 1.1]†
Fu¨gl-Meyer score in the
lower limb 28.0 ± 8.8
29.5 ± 9.0∗
[28.4 ± 8.9]†
28.5 ± 9.3
[29.0 ± 8.7]†
∗Statistically significant difference (𝑡-test, 𝑃 < 0.05).
was performed according to the manufacturer’s recommen-
dations (Nexstim): use of glasses in which spatial positioning
is detected by triangulation by means of an infrared camera,
followed by palpation of landmarks on the skull surface by a
cursor also localized in space.The error estimated by software
was verified (refusal of an error ≥2mm).
This prospective, randomized, crossover study was con-
ducted under double-blind conditions (blinded person per-
forming stimulation and randomization of the stimulation
protocols). Each patient received the 3 stimulation protocols
(Figure 1), including a placebo protocol, in random order,
using a MagProR30 stimulator in compliance with the TMS
Safety Consensus Group guidelines [17]. Each daily stimula-
tion phase lasted 16 minutes and 40 seconds, that is, 1,000
impulses, for five consecutive days. Stimulation weeks were
separated by an interval of at least one month and a complete
assessment was performed prior to each session (D0). These
assessments were repeated 4 days and 21 days (D9 then D31)
after the end of stimulation.
The first protocol consisted of continuous low frequency
1Hz stimulation at 90% of the motor threshold and the
second protocol consisted of high frequency 10Hz stimula-
tion at 100% of the motor threshold, composed of twenty
5-second trains separated by 45-second intervals. We chose
these two different frequencies according to the literature
[11, 12]. Placebo stimulationwas randomized to one of the two
frequencies with application of an audio coil, not delivering
any magnetic impulses.
2.3. Clinical Assessment
2.3.1. Spasticity. Ankle spasticity, the primary endpoint of the
study, was scored by the modified Ashworth scale [18], with
the knee flexed and the knee extended, at slow speed then at
rapid speed.
2.3.2. Neurological Assessment. Residual antagonist muscle
activity was evaluated in the supine position by the sim-
ple order: “raise your foot.” The percentage amplitude of
recruitment of antagonists was evaluated: less than 25%,
between 25% and 50%, between 50% and 75%, or between
75% and 100% (score from 1 to 4). Fine touch on the leg
and foot and proprioception of the big toe were tested with
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Table 2: Course of parameters recorded during quantitative analysis of walking (mean ± standard deviation) during the 1Hz and 10Hz (†
brackets) stimulation protocols: before (D0) and after (D9: early assessment; D31: late assessment).
Parameter D0 D9 D31
Gait velocity (m/s) 0.48 ± 0.46 0.46 ± 0.43
[0.47 ± 0.40]†
0.44 ± 0.41
[0.45 ± 0.42]†
Cadence (steps/min) 40.19 ± 10.76 38.69 ± 10.54
∗
[38.84 ± 9.57]†
38.03 ± 10.95∗
[37.87 ± 9.91]†
Stride length (m) 0.62 ± 0.48 0.63 ± 0.47
[0.62 ± 0.48]†
0.61 ± 0.45
[0.63 ± 0.44]†
Stance phase (%) 68.19 ± 10.74 67.74 ± 8.15
[68.27 ± 9.13]†
69.14 ± 9.62
[68.53 ± 8.75]†
Swing phase (%) 31.81 ± 10.74 32.26 ± 8.15
[31.73 ± 9.13]†
30.86 ± 9.62
[31.47 ± 8.75]†
Maximum knee extension (∘) −1.02 ± 5.18 −2.88 ± 4.31
[−1.72 ± 3.74]†
−4.87 ± 4.34∗
[−2.74 ± 4.41]†
Dorsiflexion of the ankle at foot strike (∘) −8.91 ± 7.14 −6.93 ± 9.41
[−7.21 ± 7.17]†
−10.61 ± 7.92
[−7.97 ± 8.74]†
Maximum dorsiflexion of the ankle during the stance phase (∘) 5.08 ± 8.73 6.68 ± 10.35
[5.70 ± 8.54]†
3.05 ± 8.13
[5.12 ± 7.52]†
Dorsiflexion of the ankle at the beginning of the swing phase (∘) −5.45 ± 3.11 −4.23 ± 4.95
[−5.32 ± 4.17]†
−7.18 ± 3.67
[−6.12 ± 3.97]†
Maximum plantar flexion of the ankle during the swing phase (∘) 10.69 ± 5.11 10.99 ± 5.28
[10.72 ± 5.41]†
13.34 ± 4.75
[11.21 ± 6.12]†
Range of ankle motion (∘) 16.58 ± 7.47 19.68 ± 5.41
∗
[17.32 ± 6.54]†
17.28 ± 6.40
[17.97 ± 5.98]†
∗Statistically significant difference (𝑡-test, 𝑃 < 0.05). Comparisons were performed between D0 and D9 (significant variation indicated in D9 column) and
then between D0 and D31 (significant variation indicated in D31 column). No significant variation was identified between D9 and D31.
Table 3: Variation of electrophysiological ratios calculated for the
soleus muscle and passive stiffness of the ankle (mean ± standard
deviation) during the 1Hz and 10Hz († brackets) stimulation
protocols: before (D0) and after (D9: early assessment; D31: late
assessment).
Parameter D0 D9 D31
𝐻max/𝑀max 0.75 ± 0.08
0.53 ± 0.08∗
[0.74 ± 0.07]†
0.49 ± 0.14∗
[0.75 ± 0.09]†
𝑇/𝑀max 0.49 ± 0.09
0.33 ± 0.10∗
[0.48 ± 0.08]†
0.33 ± 0.16∗
[0.47 ± 0.09]†
Stiffness index
(Nm/rad) 63.97 ± 21.09
61.62 ± 22.73∗
[63.54 ± 20.71]†
61.63 ± 22.39∗
[63.91 ± 21.41]†
∗Statistically significant difference (𝑡-test, 𝑃 < 0.05). Comparisons were
performed between D0 and D9 (significant variations indicated in D9
column) and then between D0 and D31 (significant variations indicated in
D31 column). No significant variation was identified between D9 and D31.
the patient’s eyes closed. Sensory assessment was scored as
normal, decreased, or absent. Pain when wearing shoes was
assessed by a visual analogue scale (VAS) from 0 to 10,
where 0 represented no pain and 10 represented the worst
imaginable pain. Finally, the global neurological recovery
score was evaluated by the Fu¨gl-Meyer scale [19, 20].8
2.4. Analysis of Walking. Quantitative analysis of walking
(QAW), performed in the movement analysis laboratory,
allows objective and systematic acquisition of spatiotemporal
and kinematic parameters [21]. Acquisition and data process-
ing systems and the positioning of markers on the patient’s
lower limbs have been previously described by our laboratory
[22]. Photographs of the position of the markers were taken
during first application of the markers to decrease the risk
of subsequent marker placement errors (Figures 2(a) and
2(b)). A static acquisition was obtained by recognition of the
markers using 6 infrared cameras (ViconMXF 40). Dynamic
acquisitions were obtained during spontaneous walking, on
a maximum of 10 passages, with bare feet in every case
and without assistance whenever possible. Conditions were
identical between the various sessions to allow objective
comparison of all parameters.
2.4.1. Spatiotemporal Parameters. The following parameters,
averaged over several cycles, were recorded for each assess-
ment: gait velocity of the affected limb (m/s), cadence
(steps/min), stride length (m), and percentages of single limb
and double limb support. 9
2.4.2. Kinematic Parameters. The position of the knee in
maximum extension was quantified to detect possible recur-
vatumdeformity.The angle of dorsiflexion at the strike phase,
maximum dorsiflexion during the stance phase and at the
beginning of the swing phase, and maximum plantar flexion
at the end of the swing phase was measured in the sagittal 10
plane of the ankle. The range of ankle motion was also
measured. 11
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Inclusion and initial evaluation
Randomisation (day 1)
Placebo
Evaluation (day 9)
Evaluation (day 31)
Evaluation (day 40)
Evaluation (day 62)
Evaluation (day 71)
Final evaluation (day 93)
1Hz 10Hz
1 or 10Hz
1 or 10Hz
Placebo or 10Hz
Placebo or 10Hz
Placebo or 1Hz
Placebo or 1Hz
5days
5days
5days
Figure 1: Design of the study.
2.5. Electromyographic Assessment. H and T reflexes and
maximum motor response (𝑀max) were recorded for each
of the three muscle heads of triceps surae, according to a
previously described technique [23]. Positioning of recording
electrodes is illustrated in Figure 2(c). Maximum peak-to-
peak amplitudes of the various responses were measured
and averaged on 10 recordings (𝐻max, 𝑀max, and T), and
𝐻max/𝑀max and T/𝑀max ratios were calculated.The duration
of H or M responses and their latencies were also calculated
for each response by manually selecting the start and end of
each response.12
2.6. Assessment of Passive Stiffness of the Ankle. Passive
stiffness of the ankle was evaluated by using an ankle
ergometric device designed by the Universite´ de Technologie
de Compie`gne [24] and by applying sinusoidal perturbations
with an amplitude of ±1.5 on either side of the ankle neutral
position to the ankle at rest (90).The frequency of sinusoidal
perturbations ranged from4 to 16Hzwith increments of 1Hz.
Application of sinusoidal perturbations induced variations of
passive torque of the ankle joint, the amplitude and dephasing
of which are frequency-dependent. A stiffness constant (Kp,
expressed inNm/rad), reflecting passive musculoarticular
stiffness of the ankle, was calculated from Bode diagrams, as
described by Lambertz et al. [25].13
2.7. Ethics Committee Approval. The study design and all
investigations were validated by Nantes University Hospital,
the study sponsor. The Comite´ de Protection des Personnes
Ouest V (IEC/IRB) issued a positive opinion to conduct
the study. The Agence Franc¸aise de Se´curite´ Sanitaire des
Produits de Sante´ (French Health Products Safety Agency)
also authorised the submitted project. All patients were
informed and signed an informed consent form.
2.8. Data Processing and Statistical Methods. Ergometric data
were analysed by Matlab (The MathWorks, Inc., Natick, MY
01760-2098, USA) using Synerg software developed in the
laboratory. EMGdata were recorded by Systemg software and
were analysed by Neuromecanik software. This software was
developed in the Compie`gne laboratory. Statistical analyses
were performed with JMP 9.0.2 software (SAS Institute INC
2010). A paired t-test was used for all comparisons of means.
The limit of significance was 0.05.
3. Results
Themean interval between the initial accident responsible for
spasticity and initiation of the protocol was 79months [range:
29–136months].The five patients complied with all aspects of
the protocol and the assessments. No serious adverse event
was observed. Two patients experienced transient headache
that resolved in response to treatment with step I analgesics.
One patient reported tiredness related to travelling to and
from the hospital for the daily visits during the week of
stimulation. No significant difference was observed for any
of the parameters studied before each stimulation session,
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which validates the reproducibility of measurements and
return to baseline before each new stimulation protocol.14
No statistically significant change or tendency to change
was observed for any of the clinical, neuromechanical, and
gait parameters after the placebo and 10Hz stimulation
protocols. Significant changes were demonstrated after the
1Hz stimulation protocol. This section will therefore be
confined to a detailed description of these changes.15
3.1. Clinical Assessment. The main clinical findings are sum-
marized in Table 1.
3.1.1. Spasticity. All patients initially presented equinovarus
deformity of the foot. No modification of this deformity was
observed at the various assessments after the stimulation pro-
tocols. No modification of the Ashworth score was observed
at the various clinical assessments performed during this
stimulation protocol, regardless of the test conditions.
3.1.2. Neurological Assessment. Clinical examination did not
reveal any changes in the motor function of the peroneal
and triceps surae muscles. In contrast, a tendency towards
improved recruitment of antagonist muscles was observed
on D9, especially for the maximum percentage angulation
of dorsiflexors under active conditions. This tendency was
amplified and became significant on D31 (Table 1: from 1 on
D0 to 1.8 on D31, t -test, 𝑃 = 0.049).
No significant difference was observed for touch sensa-
tion, but a tendency towards improvement of proprioception
was observed: 3 of the patients in whom proprioception was
absent onD0 presented decreased but present proprioception
on D9 and D31. One patient reported pain when wearing
shoes (VAS: 4) at the baseline assessment. Stimulation sup-
pressed this pain in this patient (VAS: 0 on D9 and D31).
Themean Fu¨gl-Meyer score was 28 at the baseline assess-
ment and was significantly increased at the D9 assessment
(Table 1, t-test, 𝑃 = 0.047) with return to baseline on D31.
3.2.Walking Analysis. All parameters recorded before stimu-
lation (D0) and on the early (D9) and late (D31) assessments
after the 1Hz and 10Hz stimulation protocols are presented
in Table 2.
3.2.1. Spatiotemporal Parameters. Gait velocity, stride
length, and stance phase/swing phase distribution remained
unchanged at the various assessments. Cadence significantly
decreased between D0 and D9 (t-test, 𝑃 = 0.0117) and
between D0 and D31 (𝑃 = 0.0424).
3.2.2. Kinematic Parameters. Prior to any therapeutic inter-
vention, spastic patients presented an equinus strike phase
(mean defect of ankle dorsiflexion of −8.91∘). Ankle dorsi-
flexion remained extremely limited throughout gait (Table 2).
Three patients presented recurvatum of the knee (reflected
by positive maximum knee extension values). This parame-
ter was significantly improved at the long-term assessment
(Table 2, t-test, 𝑃 = 0.042), as recurvatum was no longer
observed in these 3 patients.
3.3. Electrophysiological Assessment. Electrophysiological
parameters varied in an identical way for the 3 heads of
triceps surae. In view of the predominant role of the soleus
muscle in the spastic equine foot phenomenon, only the
variations observed in this muscle are presented here. No
significant difference was demonstrated for the mean values
of latency and duration of the various responses on all of the
measurements performed on D0, D9, and D31.
Mean 𝐻max /𝑀max and T/𝑀max ratios were significantly
decreased at the two assessments after the 1Hz protocol
(Table 3): 30% reduction of the mean 𝐻max /𝑀max ratio (t-
test, 𝑃 = 0.0295) and 33% reduction of the mean T/𝑀max
ratio (t-test, 𝑃 = 0.0006) on D9. These reductions remained
significant between D0 and D31: 35% reduction of the mean
𝐻max /𝑀max ratio (t-test, 𝑃 = 0.0394) and 33% reduction of
the mean T/𝑀max ratio (t-test, 𝑃 = 0.0168).
3.4. Assessment of Passive Stiffness of the Ankle. A slight but
significant reduction of passive stiffness of the ankle was
observed on D9 after 1Hz stimulation (Table 3, t-test, 𝑃 =
0.039). This reduction remained stable on D31.
4. Discussion
This study based on a series of 5 patients is the first random-
ized, double-blind, crossover study to assess all clinical and
complementary parameters of spasticity.Themain limitation
of this study is the small number of patients, as the main
limiting factor for recruitment is the cost of transport of these
patients who cannot travel unassisted (the study required a
total of 25 trips to and from the hospital for each patient).
This prospective study did not reveal any modification
of spastic symptoms regardless of the stimulation protocol
tested, as no variation of the Ashworth score (always eval-
uated by the same clinician) or presentation of the foot (no
variation of the equinovarus deformity after stimulation)
was demonstrated. Two studies [11, 12] assessed the clinical
parameters of spasticity and their changes after treatment
by rTMS. The first study [11] concerned a population of
patients with multiple sclerosis complicated by spasticity
but did not provide any details concerning the spinal or
cerebral site of multiple sclerosis. The stimulation target
differed from that adopted in the present study, as these
authors performed primary motor cortex stimulation. The
duration of stimulation was also longer (2 weeks) than in
our protocol. No modification of clinical parameters (the
only parameters evaluated in this study) was observed after
1Hz stimulation. However, an average 2-point reduction
of the global Ashworth score (corresponding to the sum
of modified Ashworth scores evaluated in the ankle, knee,
and hip) was demonstrated immediately after and one week
after the stimulation protocol. The second study published
in the literature [12] simultaneously evaluated neurological
recovery and improvement of spasticity in response to a low
frequency (1Hz) premotor cortex stimulation protocol in
stroke patients. A more marked improvement of spasticity
was observed after stimulation of the contralateral side to
the spastic hemiparesis, but this study reported few details
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Figure 2: Anterior (a) and posterior (b) views of optoelectronic markers and positioning of electrodes (c) on the 3 heads of triceps surae for
recording of electromyographic responsesM,H, and T. (1) Anterior superior iliac spine; (2) thigh marker; (3) lateral femoral condyle; (4) leg
marker; (5) lateral malleolus; (6) head of second metatarsus; (7) posterior superior iliac spine; (8) calcaneus. GM: medial gastrocnemius; GL:
lateral gastrocnemius; SOL: soleus.
concerning clinical parameters and used various scores that
are not validated in the literature. Overall, rTMS therefore
appears to have only a minor effect on spasticity per se,
regardless of the stimulation parameters and targets tested.
The 1Hz stimulation protocol of the premotor cortex
ipsilateral to the lesion appeared to have a positive effect
on antagonist muscle recruitment (significant facilitation of
dorsiflexion of the ankle 3 weeks after completion of the
stimulation protocol) and on the functional capacities of the
lower limb (increased Fu¨gl-Meyer score). These results are
supported by the increased range of motion of the ankle
demonstrated during quantitative analysis of walking. How-
ever, this comparison must be interpreted very cautiously,
as it is based on two different types of recruitment: active
recruitment tested during clinical examination and reflex
recruitment during walking. Moreover, no improvement of
gait was demonstrated on quantitative analysis regardless of
the type of stimulation. On the contrary, a tendency towards
slowing of gait was observed after stimulation, very probably
related to “destabilization” of the patient in relation to the
changes of two kinematic parameters observed during this
study (range of motion of the ankle and decreased recurva-
tum of the knee). Adaptation of gait to these modifications is
obviously a long process and the effect of stimulation was so
short-lived that the patient did not have time to modify gait
in order to derive a benefit from these improved parameters.
This aspect will need to be assessed in longer term studies
of repetitive stimulation protocols. An improvement of gait
would probably be observed after several repetitions of the
same 1Hz rTMS protocol.
The modifications of neuromechanical parameters of the
ankle observed in this study appear to be more promising,
as the 1Hz stimulation protocol clearly appeared to rein-
force suprasegmental inhibition (greater than 30% reduc-
tion of the 𝐻max /𝑀max and T/𝑀max ratios), while 10Hz
and placebo protocols did not induce any modification of
these parameters. Similar results were reported in a study
conducted on 10 healthy subjects after a 5Hz primary motor
cortex stimulation protocol [10]. However, this result is in
complete contradiction to the effect reported in the literature
in patients with multiple sclerosis [11], as a reduction of
this 𝐻max /𝑀max ratio was demonstrated after the 10Hz
stimulation protocol, which was not observed in the present
study. This previous study also reported a tendency towards
an increase of this ratio in healthy subjects after the 1Hz
stimulation protocol. Reduction of the 𝐻max /𝑀max ratio in
our series is supported by the reduction of the T/𝑀max ratio,
which was more marked at the early assessment, suggesting a
complementary action of rTMS on elements of the T reflex
loop not involved in the H reflex loop (spindle sensitivity,
gamma drive, and spindle recruitment by more compliant
elastic structures) [26], correlated with the reduction of
passive stiffness of the ankle observed in this study. Testing of
ankle stiffness comprises a passive component (particularly
the length and elasticity of muscle and tendon structures)
and an active component (spindle sensitivity, gamma drive,
and spindle recruitment). One hypothesis to explain this
reduction of passive stiffness would be a reduction of muscle
tone and therefore the number of residual cross-bridges,
thereby making the muscle more compliant. This effect on
the muscle tone would have consequences on both the
passive and active components of ankle stiffness. Further
investigations must be conducted on these aspects. This
effect on ankle stiffness remained stable at the long-term
assessment (stability of stiffness and T/𝑀max ratio), while the
effect of rTMS on suprasegmental inhibition was reinforced
(more marked reduction of the𝐻max /𝑀max ratio at the long-
term assessment).
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5. Conclusion
In summary, the only rTMS protocol with an objective effect
in this study was the low frequency (1Hz) protocol targeted
to the premotor cortex on the side of the lesion. Only a
moderate clinical effect was observed, predominantly on
the consequences of spasticity (recruitment of antagonists
and recurvatum) but not on spastic symptoms per se. The
observed effect appeared to be due to reinforcement of
suprasegmental inhibition acting on the H reflex loop and
a reduction of muscle tone, but these mechanisms need to
be confirmed. A long-term repetitive stimulation protocol
now needs to be proposed to enable the patient to adapt
his gait to these changes, which would therefore probably
facilitate walking, which remains the primary objective of any
therapeutic intervention designed to improve spasticity.
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